FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893721912> ?p ?o ?g. }

• W2893721912 endingPage "421" @default.
• W2893721912 startingPage "415" @default.
• W2893721912 abstract "Summary Background Misoprostol is an E prostanoid ( EP ) 2, 3 and 4 receptor agonist that is anecdotally used to treat and prevent NSAID ‐induced GI injury in horses. Misoprostol elicits anti‐inflammatory effects in vivo in men and rodents, and inhibits TNF α production in equine leucocytes in vitro. Objective Define the pharmacokinetic parameters of oral misoprostol in horses, and determine the inhibitory effect of oral misoprostol administration on equine leucocyte TNF α production in an ex vivo inflammation model. Study design Pharmacokinetic study, ex vivo experimental study. Methods Six healthy adult horses of mixed breeds were used. In phase one, horses were given 5 μg/kg misoprostol orally, and blood was collected at predetermined times for determination of misoprostol free acid ( MFA ) by UHPLC ‐ MS / MS . Pharmacokinetic parameters were calculated. In phase two, horses were dosed as in phase one, and blood was collected at T0, 0.5, 1 and 4 h following misoprostol administration for leucocyte isolation. Leucocytes were stimulated with 100 ng/mL LPS , and TNF α mRNA concentrations were determined via quantitative real‐time PCR. Results About 5 μg/kg oral misoprostol produced a rapid time to maximum concentration (T max ) of 23.4 ± 2.4 min, with a maximum concentration (C max ) of 0.29 ± 0.07 ng/mL and area under the curve ( AUC 0−∞ ) of 0.4 ± 0.12 h ng/mL. LPS stimulation of equine leucocytes ex vivo significantly increased TNF α mRNA concentrations, and there was no significant effect of misoprostol even at the T max . Main limitations Only a single dose was used, and sample size was small. Conclusions Misoprostol is rapidly absorbed following oral administration in horses, and a single 5 μg/kg dose had no significant inhibitory effect on ex vivo LPS ‐stimulated TNF α mRNA production in leucocytes. Further studies analysing different dosing strategies, including repeat administration or combination with other anti‐inflammatory drugs, are warranted." @default.
• W2893721912 created "2018-10-05" @default.
• W2893721912 creator A5001956033 @default.
• W2893721912 creator A5050047175 @default.
• W2893721912 creator A5056519418 @default.
• W2893721912 creator A5072277662 @default.
• W2893721912 date "2018-10-23" @default.
• W2893721912 modified "2023-10-13" @default.
• W2893721912 title "Pharmacokinetics and ex vivo anti‐inflammatory effects of oral misoprostol in horses" @default.
• W2893721912 cites W1477973778 @default.
• W2893721912 cites W1574699893 @default.
• W2893721912 cites W1760773223 @default.
• W2893721912 cites W1796266772 @default.
• W2893721912 cites W1920603145 @default.
• W2893721912 cites W1940681873 @default.
• W2893721912 cites W1947872995 @default.
• W2893721912 cites W1967897225 @default.
• W2893721912 cites W1975076854 @default.
• W2893721912 cites W1975895958 @default.
• W2893721912 cites W1978022169 @default.
• W2893721912 cites W1979482373 @default.
• W2893721912 cites W1991238781 @default.
• W2893721912 cites W1997442489 @default.
• W2893721912 cites W2010637767 @default.
• W2893721912 cites W2012183885 @default.
• W2893721912 cites W2012601894 @default.
• W2893721912 cites W2013056431 @default.
• W2893721912 cites W2017494004 @default.
• W2893721912 cites W2019430548 @default.
• W2893721912 cites W2032289170 @default.
• W2893721912 cites W2034516005 @default.
• W2893721912 cites W2048648009 @default.
• W2893721912 cites W2059662508 @default.
• W2893721912 cites W2067983262 @default.
• W2893721912 cites W2073316967 @default.
• W2893721912 cites W2076366503 @default.
• W2893721912 cites W2087038612 @default.
• W2893721912 cites W2093005831 @default.
• W2893721912 cites W2093049965 @default.
• W2893721912 cites W2094015039 @default.
• W2893721912 cites W2094621702 @default.
• W2893721912 cites W2118857937 @default.
• W2893721912 cites W2123449208 @default.
• W2893721912 cites W2128443399 @default.
• W2893721912 cites W2133081607 @default.
• W2893721912 cites W2136746865 @default.
• W2893721912 cites W2136990921 @default.
• W2893721912 cites W2152697664 @default.
• W2893721912 cites W2161872135 @default.
• W2893721912 cites W2229121064 @default.
• W2893721912 cites W2335488487 @default.
• W2893721912 cites W2337097729 @default.
• W2893721912 cites W2418986815 @default.
• W2893721912 cites W24668888 @default.
• W2893721912 cites W2758317802 @default.
• W2893721912 cites W2758763427 @default.
• W2893721912 cites W2916866789 @default.
• W2893721912 cites W3143651968 @default.
• W2893721912 cites W34089063 @default.
• W2893721912 cites W4253133188 @default.
• W2893721912 doi "https://doi.org/10.1111/evj.13024" @default.
• W2893721912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6587934" @default.
• W2893721912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30256450" @default.
• W2893721912 hasPublicationYear "2018" @default.
• W2893721912 type Work @default.
• W2893721912 sameAs 2893721912 @default.
• W2893721912 citedByCount "5" @default.
• W2893721912 countsByYear W28937219122019 @default.
• W2893721912 countsByYear W28937219122020 @default.
• W2893721912 countsByYear W28937219122023 @default.
• W2893721912 crossrefType "journal-article" @default.
• W2893721912 hasAuthorship W2893721912A5001956033 @default.
• W2893721912 hasAuthorship W2893721912A5050047175 @default.
• W2893721912 hasAuthorship W2893721912A5056519418 @default.
• W2893721912 hasAuthorship W2893721912A5072277662 @default.
• W2893721912 hasBestOaLocation W28937219121 @default.
• W2893721912 hasConcept C112705442 @default.
• W2893721912 hasConcept C150903083 @default.
• W2893721912 hasConcept C151730666 @default.
• W2893721912 hasConcept C207001950 @default.
• W2893721912 hasConcept C26291073 @default.
• W2893721912 hasConcept C2777056448 @default.
• W2893721912 hasConcept C2778642596 @default.
• W2893721912 hasConcept C2779199973 @default.
• W2893721912 hasConcept C2779234561 @default.
• W2893721912 hasConcept C2780762169 @default.
• W2893721912 hasConcept C54355233 @default.
• W2893721912 hasConcept C71924100 @default.
• W2893721912 hasConcept C86803240 @default.
• W2893721912 hasConcept C98274493 @default.
• W2893721912 hasConceptScore W2893721912C112705442 @default.
• W2893721912 hasConceptScore W2893721912C150903083 @default.
• W2893721912 hasConceptScore W2893721912C151730666 @default.
• W2893721912 hasConceptScore W2893721912C207001950 @default.
• W2893721912 hasConceptScore W2893721912C26291073 @default.
• W2893721912 hasConceptScore W2893721912C2777056448 @default.
• W2893721912 hasConceptScore W2893721912C2778642596 @default.
• W2893721912 hasConceptScore W2893721912C2779199973 @default.

• next